Definition of XL820

An orally available, small molecule receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic activity. XL820 simultaneously inhibits the RTKs, VEGF, KIT and PDGF. In tumor models of breast carcinomas, gliomas and leukemia, this agent exhibits dose-dependent growth inhibition and has been shown to cause tumor regression.

XL820 is from the group

Tyrosine Kinase Inhibitor

Other Names for XL820



NCI Thesaurus License

Topics #XL820